Literature DB >> 35028562

Functionalized resorcinarenes effectively disrupt the aggregation of αA66-80 crystallin peptide related to cataracts.

Kwaku Twum1, Avik Bhattacharjee2, Erving T Laryea1, Josephine Esposto3, George Omolloh2, Shaelyn Mortensen3, Maya Jaradi1, Naomi L Stock4, Nicholas Schileru1,5, Bianca Elias1, Elan Pszenica1, Theresa M McCormick2, Sanela Martic3,4, Ngong Kodiah Beyeh1.   

Abstract

Cataracts, an eye lens clouding disease, are debilitating and while operable, remain without a cure. αA66-80 crystallin peptide abundant in cataracted eye lenses contributes to aggregation of αA-crystallin protein leading to cataracts. Inspired by the versatility of macrocycles and programmable guest selectivity through discrete functionalizations, we report on three water-soluble ionic resorcinarene receptors (A, B, and C) that disrupt the aggregation of αA66-80 crystallin peptide. A and B each possess four anionic sulfonate groups, while C includes four cationic ammonium groups with four flexible extended benzyl groups. Through multiple non-covalent attractions, these receptors successfully disrupt and reverse the aggregation of αA66-80 crystallin peptide, which was studied through spectroscopic, spectrometric, calorimetric, and imaging techniques. The αA66-80·receptor complexes were also explored using molecular dynamics simulation, and binding energies were calculated. Even though each of the three receptors can bind with the peptide, receptor C was characterized by the highest binding energy and affinity for three different domains of the peptide. In effect, the most efficient inhibitor was a cationic receptor C via extended aromatic interactions. These results highlight the potential of versatile and tunable functionalized resorcinarenes as potential therapeutics to reverse the aggregation of α-crystallin dominant in eye cataracts. This journal is © The Royal Society of Chemistry.

Entities:  

Year:  2021        PMID: 35028562      PMCID: PMC8672818          DOI: 10.1039/d1md00294e

Source DB:  PubMed          Journal:  RSC Med Chem        ISSN: 2632-8682


  27 in total

1.  DRUG DISCOVERY. A new dawn for cataracts.

Authors:  Roy A Quinlan
Journal:  Science       Date:  2015-11-06       Impact factor: 47.728

2.  Lysine-specific molecular tweezers are broad-spectrum inhibitors of assembly and toxicity of amyloid proteins.

Authors:  Sharmistha Sinha; Dahabada H J Lopes; Zhenming Du; Eric S Pang; Akila Shanmugam; Aleksey Lomakin; Peter Talbiersky; Annette Tennstaedt; Kirsten McDaniel; Reena Bakshi; Pei-Yi Kuo; Michael Ehrmann; George B Benedek; Joseph A Loo; Frank-Gerrit Klärner; Thomas Schrader; Chunyu Wang; Gal Bitan
Journal:  J Am Chem Soc       Date:  2011-09-29       Impact factor: 15.419

3.  A novel "molecular tweezer" inhibitor of α-synuclein neurotoxicity in vitro and in vivo.

Authors:  Shubhangi Prabhudesai; Sharmistha Sinha; Aida Attar; Aswani Kotagiri; Arthur G Fitzmaurice; Rajeswari Lakshmanan; Ravi Lakshmanan; Magdalena I Ivanova; Joseph A Loo; Frank-Gerrit Klärner; Thomas Schrader; Mark Stahl; Gal Bitan; Jeff M Bronstein
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

4.  The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin.

Authors:  W L Jorgensen; J Tirado-Rives
Journal:  J Am Chem Soc       Date:  1988-03-01       Impact factor: 15.419

5.  Resveratrol reduces amyloid-beta (Aβ₁₋₄₂)-induced paralysis through targeting proteostasis in an Alzheimer model of Caenorhabditis elegans.

Authors:  Charlotte Regitz; Elena Fitzenberger; Friederike Luise Mahn; Lisa Marie Dußling; Uwe Wenzel
Journal:  Eur J Nutr       Date:  2015-04-08       Impact factor: 5.614

Review 6.  Protein misfolding and aggregation in cataract disease and prospects for prevention.

Authors:  Kate L Moreau; Jonathan A King
Journal:  Trends Mol Med       Date:  2012-04-19       Impact factor: 11.951

7.  Effect of aging on the chaperone-like function of human alpha-crystallin assessed by three methods.

Authors:  B K Derham; J J Harding
Journal:  Biochem J       Date:  1997-12-15       Impact factor: 3.857

8.  DOCK 6: Impact of new features and current docking performance.

Authors:  William J Allen; Trent E Balius; Sudipto Mukherjee; Scott R Brozell; Demetri T Moustakas; P Therese Lang; David A Case; Irwin D Kuntz; Robert C Rizzo
Journal:  J Comput Chem       Date:  2015-06-05       Impact factor: 3.376

Review 9.  Genetics of crystallins: cataract and beyond.

Authors:  Jochen Graw
Journal:  Exp Eye Res       Date:  2008-11-01       Impact factor: 3.467

Review 10.  Advances in pharmacotherapy of cataracts.

Authors:  Jingjie Xu; Qiuli Fu; Xiangjun Chen; Ke Yao
Journal:  Ann Transl Med       Date:  2020-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.